When a new health technology is evaluated in the UK, the National Institute for Health and Care Excellence (NICE) needs a consistent way to compare it against other options. This is where the Reference Case comes in. It's a set of standard rules and methods that all manufacturers must follow when submitting evidence for a Health Technology Assessment (HTA).

Think of it as a detailed recipe. By making sure everyone uses the same ingredients and instructions, NICE can make fairer, more consistent decisions. These requirements, detailed in the 2022 NICE health technology evaluation manual, ensure that every analysis of clinical and cost-effectiveness is built on the same foundation.

Every economic evaluation is done from a specific viewpoint. For NICE, the official perspective is that of the NHS and Personal Social Services (PSS). This means the analysis should only consider costs and consequences that directly affect these two sectors.

Costs like a patient's travel to a hospital or time off work are not included because they fall outside this specific scope. The focus is strictly on the resources consumed by the publicly funded health and social care system. This narrow focus ensures that decisions are based on the direct budgetary impact to the NHS and PSS.

The primary measure of health benefit in a NICE appraisal is the Quality-Adjusted Life Year (QALY). This single metric combines both the quantity and quality of life gained from an intervention. To calculate QALYs, you need a standardised way to measure a patient's health-related quality of life.

NICE's preferred tool for this is the EQ-5D-5L questionnaire. This instrument asks patients to rate their health across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels of severity. The resulting health state can be converted into a single 'utility' score, which is the quality-of-life component of the QALY calculation.

Most health technologies involve costs and benefits that stretch over many years. However, a health benefit or a cost today is generally valued more highly than the same benefit or cost in the future. To account for this, NICE requires a process called discounting.

Discounting converts future costs and health effects into their 'present value', allowing for a fair comparison of interventions with different time horizons. The Reference Case specifies that a 3.5% discount rate must be applied annually to both costs and QALYs.

Now, let's test your knowledge of the NICE Reference Case.

Understanding these core components of the Reference Case is the first step in building an analysis that meets NICE's rigorous standards for evidence.